Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Ischemic Heart Disease

Free Subscription 15.04.2024 1 Am Heart J 4 Am J Cardiol 1 Angiology 2 Ann Intern Med 1 Arterioscler Thromb Vasc Biol 3 Atherosclerosis 1 Can J Cardiol 1 Chest 1 Circ Cardiovasc Interv 1 Circ Cardiovasc Qual Outcomes 1 Circ Genom Precis Med 1 Circ J 5 Circulation 7 Eur Heart J 1 Hypertension 8 Int J Cardiol 9 J Am Coll Cardiol 1 J Cardiovasc Pharmacol 1 J Clin Endocrinol Metab 1 J Mol Cell Cardiol 2 JAMA 6 Lancet 1 Mol Cell Biochem 8 N Engl J Med 4 PLoS One 1 Prog Cardiovasc Dis 1 Psychosom Med

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. DAUBERT MA, Stebbins A, Peragallo-Urrutia R, Chiswell K, et al
   Early Postpartum Blood Pressure Screening is Associated with Increased Detection of Cardiovascular Risk Factors in Women with Hypertensive Disorders of Pregnancy.
   Am Heart J. 2024 Apr 4:S0002-8703(24)00076-0. doi: 10.1016/j.ahj.2024.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

2. SAHA A, Li S, de Lemos JA, Pandey A, et al
   Characteristics of High-Performing Hospitals in Cardiogenic Shock Following Acute Myocardial Infarction.
   Am J Cardiol. 2024 Apr 5:S0002-9149(24)00237.
   PubMed         Abstract available
   
   
3. CHEEMA HA, Bhanushali K, Sohail A, Fatima A, et al
   Immediate Versus Staged Complete Revascularization in Patients With Acute Coronary Syndrome: a Systematic Review and Meta-Analysis of Randomized Controlled Trials.
   Am J Cardiol. 2024 Apr 4:S0002-9149(24)00239.
   PubMed         Abstract available
   
   
4. WIDMER RJ, Hammonds K, Mixon T, Exaire JE, et al
   Acute coronary syndrome revascularization strategies with multi-vessel coronary artery disease.
   Am J Cardiol. 2024 Apr 4:S0002-9149(24)00236.
   PubMed         Abstract available
   
   
5. REVANKAR S, Agarwala A
   Stepping Away from the Monolith: The Disaggregation of Asian Cardiovascular Data.
   Am J Cardiol. 2024 Apr 4:S0002-9149(24)00231.
   PubMed        
   
   

   
   Angiology

6. MURAT B, Murat S, Gorenek B
   Comment on the Association of Coronary Artery Severity and Late In-Stent Restenosis: An Angiographic Imaging Study.
   Angiology. 2024 Apr 9:33197241246917. doi: 10.1177/00033197241246917.
   PubMed        
   
   

   
   Ann Intern Med

7. GREENWOOD H, Barnes K, Clark J, Ball L, et al
   Long-Term Effect of Salt Substitution for Cardiovascular Outcomes : A Systematic Review and Meta-Analysis.
   Ann Intern Med. 2024 Apr 9. doi: 10.7326/M23-2626.
   PubMed         Abstract available
   
   
8. 
   Annals Video Summary - Long-Term Effect of Salt Substitution for Cardiovascular Outcomes: A Systematic Review and Meta-analysis.
   Ann Intern Med. 2024 Apr 9:eM240208. doi: 10.7326/M24-0208.
   PubMed        
   
   

   
   Arterioscler Thromb Vasc Biol

9. SELVARAJAN I, Kiema M, Huang RT, Li J, et al
   Coronary Artery Disease Risk Variant Dampens the Expression of CALCRL by Reducing HSF Binding to Shear Stress Responsive Enhancer in Endothelial Cells In Vitro.
   Arterioscler Thromb Vasc Biol. 2024 Apr 11. doi: 10.1161/ATVBAHA.123.318964.
   PubMed         Abstract available
   
   

   
   Atherosclerosis

10. RINALDI R, Colucci M, Torre I, Ausiello D, et al
    Predicting the response to acetylcholine in ischemia or infarction with non-obstructive coronary arteries: The ABCD score.
    Atherosclerosis. 2024;391:117503.
    PubMed         Abstract available
    
    
11. HAN Y, Ren L, Fei X, Wang J, et al
    Effect of combining evolocumab with statin on carotid intraplaque neovascularization in patients with premature coronary artery disease (EPOCH).
    Atherosclerosis. 2024;391:117471.
    PubMed         Abstract available
    
    
12. GAGNON E, Arsenault BJ
    Drug target Mendelian randomization supports apolipoprotein C3-lowering for lipoprotein-lipid levels reductions and cardiovascular diseases prevention.
    Atherosclerosis. 2024;391:117501.
    PubMed         Abstract available
    
    

    
    Can J Cardiol

13. ROBERT YAO RJ, Fordyce CB
    Optimal transfusion threshold for anemic patients presenting with myocardial infarction and heart failure: dream or REALITY?
    Can J Cardiol. 2024 Apr 9:S0828-282X(24)00299-X. doi: 10.1016/j.cjca.2024.
    PubMed        
    
    

    
    Chest

14. ARON J, Baldomero AK, Rau A, Fiecas MB, et al
    Individual Risk Factors of PM(2.5) Associated With Wintertime Mortality in Urban Patients With COPD.
    Chest. 2024;165:825-835.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Interv

15. HARKIN KL, Loftspring E, Beaty W, Joa A, et al
    Visual Estimates of Coronary Slow Flow Are Not Associated with Invasive Wire-Based Diagnoses of Coronary Microvascular Dysfunction.
    Circ Cardiovasc Interv. 2024 Apr 7. doi: 10.1161/CIRCINTERVENTIONS.123.013902.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Qual Outcomes

16. WADHERA RK, Secemsky EA, Xu J, Yeh RW, et al
    Community Socioeconomic Status, Acute Cardiovascular Hospitalizations, and Mortality in Medicare, 2003 to 2019.
    Circ Cardiovasc Qual Outcomes. 2024 Apr 10:e010090.
    PubMed         Abstract available
    
    

    
    Circ Genom Precis Med

17. HENRY J, Lin Y, Bouatia-Naji N
    Enhancing the Prediction Power of Polygenic Risk Scores in Genetically Diverse Coronary Heart Disease.
    Circ Genom Precis Med. 2024 Apr 8:e004610. doi: 10.1161/CIRCGEN.124.004610.
    PubMed        
    
    

    
    Circ J

18. KIM CH, Lee SH, Kim HK, Kim MC, et al
    Prognostic Implications of N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Non-ST-Elevation Myocardial Infarction.
    Circ J. 2024 Apr 11. doi: 10.1253/circj.CJ-24-0129.
    PubMed         Abstract available
    
    

    
    Circulation

19. HERNANDEZ AF, Udell JA, Jones WS, Anker SD, et al
    Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights from the EMPACT-MI Trial.
    Circulation. 2024 Apr 6. doi: 10.1161/CIRCULATIONAHA.124.069217.
    PubMed         Abstract available
    
    
20. GOLDFARB MJ, Saylor MA, Bozkurt B, Code J, et al
    Patient-Centered Adult Cardiovascular Care: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Apr 11. doi: 10.1161/CIR.0000000000001233.
    PubMed         Abstract available
    
    
21. PATEL SM, Kang YM, Im K, Neuen BL, et al
    Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.
    Circulation. 2024 Apr 7. doi: 10.1161/CIRCULATIONAHA.124.069568.
    PubMed         Abstract available
    
    
22. FANAROFF AC, Patel MS, Chokshi N, Coratti S, et al
    Effect of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients at High Risk of Cardiovascular Events: The BE ACTIVE Randomized Controlled Trial.
    Circulation. 2024 Apr 7. doi: 10.1161/CIRCULATIONAHA.124.069531.
    PubMed         Abstract available
    
    
23. CHO L, Plutzky J, Brennan D, Louie MJ, et al
    Impact of Bempedoic Acid on Cardiovascular Outcomes by Sex.
    Circulation. 2024 Apr 6. doi: 10.1161/CIRCULATIONAHA.123.067691.
    PubMed        
    
    

    
    Eur Heart J

24. BHATT AS, Johansen ND, Modin D, Claggett BL, et al
    Electronic nudges increase influenza vaccination utilization after myocardial infarction: the nationwide NUDGE-FLU implementation trial.
    Eur Heart J. 2024 Apr 10:ehae235. doi: 10.1093.
    PubMed        
    
    
25. CREA F
    The complex interaction between cancer, ischaemic heart disease, and heart failure, and a focus on arrhythmias including risk stratification in Brugada syndrome and leadless pacing.
    Eur Heart J. 2024;45:1183-1187.
    PubMed        
    
    
26. KASKI JC, Al-Lamee R, Boden WE
    The year in cardiovascular medicine 2023: the top 10 papers in ischaemic heart disease.
    Eur Heart J. 2024;45:1201-1204.
    PubMed        
    
    
27. AMERI P, Bertero E, Lombardi M, Porto I, et al
    Ischaemic heart disease in patients with cancer.
    Eur Heart J. 2024;45:1209-1223.
    PubMed         Abstract available
    
    
28. BYRNE R, Coughlan JJ, Rossello X, Ibanez B, et al
    The '10 commandments' for the 2023 ESC Guidelines for the management of acute coronary syndromes.
    Eur Heart J. 2024;45:1193-1195.
    PubMed        
    
    
29. CALLEGARI A, Bonnet D, Malekzadeh-Milani S
    Successful percutaneous treatment of perinatal complete left coronary thrombotic occlusion.
    Eur Heart J. 2024;45:1285.
    PubMed        
    
    
30. LU ZN, Yang Y, Song G
    A patient-tailored clipping strategy of transcatheter edge-to-edge repair as salvage for cardiogenic shock complicated by mitral valve cleft and bileaflet flails.
    Eur Heart J. 2023 Nov 29:ehad802. doi: 10.1093.
    PubMed        
    
    

    
    Hypertension

31. DZIEDZIC M, Jozefczuk E, Guzik TJ, Siedlinski M, et al
    Interplay Between Plasma Glycine and Branched-Chain Amino Acids Contributes to the Development of Hypertension and Coronary Heart Disease.
    Hypertension. 2024 Apr 8. doi: 10.1161/HYPERTENSIONAHA.123.22649.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

32. UELAND T, Butt N, Lekva T, Orn S, et al
    High dose statin treatment reduces circulating Dickkopf-1 following acute myocardial infarction.
    Int J Cardiol. 2024 Apr 9:132035. doi: 10.1016/j.ijcard.2024.132035.
    PubMed         Abstract available
    
    
33. YILDIRIM M, Giannitsis E, Mueller-Hennessen M
    Reply to: Kavsak et al. The clinical chemistry score (CCS) achieves the highest efficacy when assessed with the 99% sensitivity benchmark for myocardial infarction.
    Int J Cardiol. 2024 Apr 6:132030. doi: 10.1016/j.ijcard.2024.132030.
    PubMed        
    
    
34. CHENG Y, Zhang Q
    Comment on "Subclinical myocardial injury increases the risk of heart failure in patients with and without type 2 diabetes post-acute coronary syndrome".
    Int J Cardiol. 2024 Mar 26:131979. doi: 10.1016/j.ijcard.2024.131979.
    PubMed        
    
    
35. MCCHORD J, Ong P
    Advancing precision medicine in INOCA research: The INOCA-IT registry.
    Int J Cardiol. 2024;404:131975.
    PubMed        
    
    
36. SHIBA M, Kato T, Seko Y, Minamino-Muta E, et al
    Cobalt protoporphyrin promotes heme oxygenase 1 expression and ameliorates cardiac dysfunction in long-term fasting mice.
    Int J Cardiol. 2024;404:131972.
    PubMed         Abstract available
    
    
37. STERPETTI AV, Gabriele R, Di Marzo L
    Sex disparities for clinical outcomes after percutaneous coronary intervention for acute coronary syndrome.
    Int J Cardiol. 2024;404:131937.
    PubMed        
    
    
38. BACIGALUPI E, Pelliccia F, Zimarino M
    Diabetes mellitus and in-stent restenosis: A direct link or something more?
    Int J Cardiol. 2024;404:131922.
    PubMed        
    
    
39. GOLINO M, Harding D, Del Buono MG, Fanti S, et al
    Innate and adaptive immunity in acute myocarditis.
    Int J Cardiol. 2024;404:131901.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

40. POVSIC TJ, Korjian S, Bahit MC, Chi G, et al
    Effect of CSL112 on Recurrent Myocardial Infarction and Cardiovascular Death: Insights from the AEGIS-II Trial.
    J Am Coll Cardiol. 2024 Mar 25:S0735-1097(24)06702.
    PubMed         Abstract available
    
    
41. UDELL JA, Petrie MC, Jones WS, Anker SD, et al
    Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction.
    J Am Coll Cardiol. 2024 Apr 1:S0735-1097(24)06757.
    PubMed         Abstract available
    
    
42. ELIAS P, Jain S, Poterucha T, Randazzo M, et al
    Artificial Intelligence for Cardiovascular Care - Part 1: Advances: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2024 Mar 26:S0735-1097(24)06742.
    PubMed         Abstract available
    
    
43. BOROVAC JA
    Unlocking the Gates of ISCHEMIA: Moving Toward Personalized Angina Management for Chronic Coronary Syndrome.
    J Am Coll Cardiol. 2024;83:1367-1369.
    PubMed        
    
    
44. ARNOLD SV, Jones PG, Maron DJ, Cohen DJ, et al
    Variation in Health Status With Invasive vs Conservative Management of Chronic Coronary Disease.
    J Am Coll Cardiol. 2024;83:1353-1366.
    PubMed         Abstract available
    
    
45. JAIN S, Elias P, Poterucha T, Randazzo M, et al
    Artificial Intelligence in Cardiovascular Care - Part 2: Applications: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2024 Mar 26:S0735-1097(24)06744.
    PubMed         Abstract available
    
    
46. OKOH AK, Amponsah MKD, Cheffet-Walsh S, Patel M, et al
    Prevalence of Cardiovascular Disease and Risk Factors among National Football League Alumni and Family Members.
    J Am Coll Cardiol. 2024 Mar 12:S0735-1097(24)00988.
    PubMed         Abstract available
    
    
47. ALSHAHRANI NS, Hartley A, Howard J, Hajhosseiny R, et al
    Remote Acute Assessment of Cardiac Patients Post-Acute Coronary Syndrome (TELE-ACS): A Randomized Controlled Trial.
    J Am Coll Cardiol. 2024 Mar 28:S0735-1097(24)06709.
    PubMed         Abstract available
    
    
48. MINHAS AMK, Mathew RO, Sperling LS, Nambi V, et al
    Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in the United States.
    J Am Coll Cardiol. 2024 Apr 1:S0735-1097(24)00940.
    PubMed        
    
    

    
    J Cardiovasc Pharmacol

49. ZHANG M, Peng W, Yin S, Zhao Y, et al
    Nondual Antiplatelet Therapy Versus Dual Antiplatelet Therapy Before Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis.
    J Cardiovasc Pharmacol. 2024;83:297-305.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

50. SONG X, Xiong L, Guo T, Chen X, et al
    Cystatin C is a predictor for long-term All-Cause and Cardiovascular Mortality in US Adults with Metabolic Syndrome.
    J Clin Endocrinol Metab. 2024 Apr 10:dgae225. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Mol Cell Cardiol

51. ANTIPENKO S, Mayfield N, Jinno M, Gunzer M, et al
    Neutrophils are indispensable for adverse cardiac remodeling in heart failure.
    J Mol Cell Cardiol. 2024;189:1-11.
    PubMed         Abstract available
    
    

    
    JAMA

52. HARRIS E
    Study Examines Intermittent Fasting and Cardiovascular Mortality.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5158.
    PubMed        
    
    
53. WU F, Jacobs DR Jr, Daniels SR, Kahonen M, et al
    Non-High-Density Lipoprotein Cholesterol Levels From Childhood to Adulthood and Cardiovascular Disease Events.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.4819.
    PubMed         Abstract available
    
    

    
    Lancet

54. STEINER-GAGER GM, Siller-Matula JM
    Abbreviated dual antiplatelet therapy after acute coronary syndrome.
    Lancet. 2024 Apr 5:S0140-6736(24)00586-5. doi: 10.1016/S0140-6736(24)00586.
    PubMed        
    
    
55. GE Z, Kan J, Gao X, Raza A, et al
    Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial.
    Lancet. 2024 Apr 5:S0140-6736(24)00473-2. doi: 10.1016/S0140-6736(24)00473.
    PubMed         Abstract available
    
    
56. BOROVAC JA
    Percutaneous coronary intervention for non-obstructive vulnerable plaques.
    Lancet. 2024 Apr 4:S0140-6736(24)00488-4. doi: 10.1016/S0140-6736(24)00488.
    PubMed        
    
    
57. DEN DEKKER WK
    Is intravascular imaging the future of percutaneous coronary intervention?
    Lancet. 2024 Apr 5:S0140-6736(24)00430-6. doi: 10.1016/S0140-6736(24)00430.
    PubMed        
    
    
58. LI X, Ge Z, Kan J, Anjum M, et al
    Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre, randomised trial.
    Lancet. 2024 Apr 5:S0140-6736(24)00282-4. doi: 10.1016/S0140-6736(24)00282.
    PubMed         Abstract available
    
    
59. PARK SJ, Ahn JM, Kang DY, Yun SC, et al
    Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial.
    Lancet. 2024 Apr 4:S0140-6736(24)00413-6. doi: 10.1016/S0140-6736(24)00413.
    PubMed         Abstract available
    
    

    
    Mol Cell Biochem

60. YANG X, Wu H, Zhou G, Zhang D, et al
    Autosis: a new form of cell death in myocardial ischemia-reperfusion injury.
    Mol Cell Biochem. 2024 Apr 9. doi: 10.1007/s11010-024-04988.
    PubMed         Abstract available
    
    

    
    N Engl J Med

61. BERGMARK BA, Marston NA, Prohaska TA, Alexander VJ, et al
    Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk.
    N Engl J Med. 2024 Apr 7. doi: 10.1056/NEJMoa2402309.
    PubMed         Abstract available
    
    
62. KUNADIAN V
    Role of Physiology in the Management of Nonculprit Lesions in Acute Coronary Syndrome.
    N Engl J Med. 2024 Apr 8. doi: 10.1056/NEJMe2403527.
    PubMed        
    
    
63. MANRIQUE-ACEVEDO C, Hirsch IB, Eckel RH
    Prevention of Cardiovascular Disease in Type 1 Diabetes.
    N Engl J Med. 2024;390:1207-1217.
    PubMed        
    
    
64. BUTLER J, Jones WS, Udell JA, Anker SD, et al
    Empagliflozin after Acute Myocardial Infarction.
    N Engl J Med. 2024 Apr 6. doi: 10.1056/NEJMoa2314051.
    PubMed         Abstract available
    
    
65. YNDIGEGN T, Lindahl B, Mars K, Alfredsson J, et al
    Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction.
    N Engl J Med. 2024 Apr 7. doi: 10.1056/NEJMoa2401479.
    PubMed         Abstract available
    
    
66. ROULEAU J
    Decreasing the Risk of Heart Failure in a Changing Post-Myocardial Infarction Environment.
    N Engl J Med. 2024 Apr 6. doi: 10.1056/NEJMe2402719.
    PubMed        
    
    
67. GIBSON CM, Duffy D, Korjian S, Bahit MC, et al
    Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction.
    N Engl J Med. 2024 Apr 6. doi: 10.1056/NEJMoa2400969.
    PubMed         Abstract available
    
    
68. BOHM F, Mogensen B, Engstrom T, Stankovic G, et al
    FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction.
    N Engl J Med. 2024 Apr 8. doi: 10.1056/NEJMoa2314149.
    PubMed         Abstract available
    
    

    
    PLoS One

69. CAO Y, Feng Y, Xia N, Zhang J, et al
    Causal associations of particulate matter 2.5 and cardiovascular disease: A two-sample mendelian randomization study.
    PLoS One. 2024;19:e0301823.
    PubMed         Abstract available
    
    
70. EL-MALAHI O, Mohajeri D, Mincu R, Bauerle A, et al
    Beneficial impacts of physical activity on heart rate variability: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0299793.
    PubMed         Abstract available
    
    
71. ZHANG Z, Chen Y, Fu X, Chen L, et al
    Identification of PPARG as key gene to link coronary atherosclerosis disease and rheumatoid arthritis via microarray data analysis.
    PLoS One. 2024;19:e0300022.
    PubMed         Abstract available
    
    
72. WU J, Tao G, Xiao H
    Association of different milk fat content with coronary artery disease and myocardial infarction risk: A Mendelian randomization study.
    PLoS One. 2024;19:e0300513.
    PubMed         Abstract available
    
    

    
    Prog Cardiovasc Dis

73. JAISWAL V, Sawhney A, Nebuwa C, Borra V, et al
    Association between testosterone replacement therapy and cardiovascular outcomes: A meta-analysis of 30 randomized controlled trials.
    Prog Cardiovasc Dis. 2024 Apr 5:S0033-0620(24)00055.
    PubMed         Abstract available
    
    

    
    Psychosom Med

74. CONNOR A, Deschamps A, Busque L, Tardif JC, et al
    Childhood Maltreatment and Leukocyte Telomere Length: Cardiac Vagal Activity Influences the Relation in Older Adults.
    Psychosom Med. 2024;86:146-156.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.